A detailed history of Criterion Capital Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Criterion Capital Advisors, LLC holds 562 shares of MRK stock, worth $55,104. This represents 0.04% of its overall portfolio holdings.

Number of Shares
562
Previous 562 -0.0%
Holding current value
$55,104
Previous $69.6 Million -0.0%
% of portfolio
0.04%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 17, 2024

SELL
$113.24 - $131.95 $17,099 - $19,924
-151 Reduced 21.18%
562 $74.2 Million
Q4 2023

Jan 31, 2024

BUY
$100.18 - $109.02 $71,428 - $77,731
713 New
713 $77.7 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Criterion Capital Advisors, LLC Portfolio

Follow Criterion Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Criterion Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Criterion Capital Advisors, LLC with notifications on news.